Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 1.72% | $2.66B | €328.05B | 31.57% | 76 Outperform | |
| AstraZeneca | 1.25% | $1.94B | £216.01B | 33.03% | 76 Outperform | |
| Roche Holding AG | 1.19% | $1.84B | CHF248.67B | 33.10% | 73 Outperform | |
| Nestlé SA | 1.13% | $1.75B | CHF203.55B | 14.56% | 71 Outperform | |
| SAP SE | 1.10% | $1.71B | €242.18B | -7.97% | 66 Neutral | |
| HSBC Holdings | 1.06% | $1.64B | £180.00B | 42.84% | 79 Outperform | |
| Novartis AG | 1.06% | $1.64B | CHF196.03B | 12.04% | 80 Outperform | |
| Shell (UK) | 0.95% | $1.48B | £158.94B | 7.69% | 77 Outperform | |
| Siemens | 0.86% | $1.33B | €174.65B | 22.38% | 74 Outperform | |
| Toyota Motor | 0.83% | $1.29B | ¥40.36T | 16.23% | 81 Outperform |